Clinical trial NCT02909101: Project IMPACT: Improving Memory Performance by Applying Cognitive Training
Official title: Cognitive Training to Reduce Impulsivity in HIV-infected Cocaine Users
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cocaine Use Disorders
HIV
Keywords: Working memory
cognitive training
HIV
substance abuse
Lead sponsor: Duke University
Sponsor class: OTHER
First posted: 2016-09-21
Enrollment: 58
Sex: ALL
Minimum age (years): 18
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to examine the effects of a cognitive training program in persons with Human Immunodeficiency Virus (HIV) infection who have used cocaine. This study tests the feasibility and preliminary efficacy of a computerized cognitive training program to improve working memory and decrease impulsivity (delay discounting) among HIV-infected individuals.

Detailed description: Of the 1.2 million Americans living with HIV, over half experience neurocognitive impairments (NCI) that adversely affect daily living and are predictive of increased morbidity and mortality. HIV-infected individuals who are addicted to stimulant drugs like cocaine are at even higher risk for NCI, which contributes to impulsive decision making, and engage in high rates of risky behaviors that are associated with both poor clinical outcomes and HIV transmission to others. Delay discounting, a key aspect of impulsivity, describes the tendency to devalue a reward as the delay to its receipt increases. Individuals addicted to drugs tend to prefer smaller, immediate rewards over larger, delayed rewards. Excessive discounting is associated with a wide range of other health risk behaviors, including risky sex. The Competing Neurobehavioral Decision Systems model posits that excessive discounting results from greater relative strength of the impulsive system over the executive control system. The investigators' own work suggests that HIV infection modulates the effect of cocaine on brain functioning in the executive control network during delay discounting. Prior research supports a robust association between excessive discounting and working memory impairment. As a core executive function that supports self-regulation, working memory is theoretically an intervention target for HIV risk reduction. Computerized working memory training has been shown to decrease delay discounting in stimulant users, but it has not yet been tested in HIV-infected drug users. The proposed R21 study will test the preliminary efficacy of a computerized cognitive training program to improve working memory and reduce delay discounting in HIV-infected cocaine users. Using a randomized trial design, the investigators will assign 50 participants to either the experimental cognitive training condition or an attention-matched control condition. Participants will complete 48 sessions in 8 weeks, with assessments at baseline, post-training, and 1-month follow-up to evaluate intervention effects. The investigators hypothesize that cognitive training will, relative to the control condition, lead to greater improvements in working memory and reductions in delay discounting. The investigators will also examine change in HIV risk behaviors (cocaine use, risky sex, and medication adherence). Results will support an R01 application for a larger scale trial to rigorously test the impact of cognitive training on HIV-related behavioral and clinical outcomes. This innovative line of research has important translational implications for HIV clinical practice, including dissemination in resource-limited settings with few neuropsychology specialists. This proposal directly advances a high priority topic for AIDS-designated funding by testing a novel treatment for HIV-associated NCI in drug users. By focusing on a high-risk population that continues to drive HIV transmission, this research has strong potential to improve neurobehavioral functioning in HIV-infected persons, and ultimately to reduce the incidence of new HIV infections.

Eligibility criteria: Inclusion Criteria:

* HIV infection
* currently on antiretroviral medications for \>3 months
* cocaine use as defined by crack/cocaine use in the past month, cocaine-type stimulant use disorder, and cocaine as the principal substance of abuse
* working memory impairment as defined by scoring \>1 standard deviation below the normative mean on at least 2 out of the 3 working memory tests

Exclusion Criteria:

* pregnancy
* English non-fluency or illiteracy
* \<8th grade education
* serious neurological disorders including HIV dementia, traumatic brain injury, severe mental illness, or acute psychiatric distress
* impaired mental status
* individuals who state they are planning to move away from the area within the next 3 months
* individuals without stable housing

Primary outcomes:
measure: Working Memory Assessed by Domain Deficit Score
timeFrame: Baseline; post-training, approximately 8 weeks
Secondary outcomes:
measure: Delay Discounting, Measured by the Monetary Choice Questionnaire (MCQ)
timeFrame: Baseline; post-training, approximately 8 weeks
measure: Acceptability as Measured by Participant Ratings
timeFrame: Post-training, approximately 8 weeks
measure: Acceptability as Measured by Participant Perception of Benefits and Barriers to Completing Sessions
timeFrame: Post-training, approximately 8 weeks
measure: Percent Medication Adherence Across All Antiretroviral Medications
timeFrame: Baseline; post-training, approximately 8 weeks
measure: Sexual Risk Behavior as Measured by the Risk Assessment Battery (RAB)
timeFrame: Baseline; post-training, approximately 8 weeks
measure: Number of Days of Cocaine Use as Measured by Timeline Followback Interview Methodology
timeFrame: Baseline; post-training, approximately 8 weeks
Other outcomes:
Locations:
city: Durham
country: United States
facility: Duke University Medical Center
state: North Carolina
Study officials:
affiliation: Duke University
name: Christina S. Meade, PhD
role: PRINCIPAL_INVESTIGATOR
References: